Literature DB >> 26913463

Unplanned Reoperation of Lumbar Spinal Surgery During the Primary Admission: A Multicenter Study Based on a Large Patient Population.

Jia-Ming Liu1, Hui-Lin Deng, Ai-Fen Peng, Jian-Ying He, Hao Li, Shan-Hu Huang, Zhi-Li Liu.   

Abstract

STUDY
DESIGN: A retrospective study.
OBJECTIVE: The purpose of this study was to identify the rates and reasons, and the risk factors for unplanned reoperation of lumbar spinal surgery during the primary admission in terms of a multicenter and a large patient population study. SUMMARY OF BACKGROUND DATA: Unplanned reoperation is suggested to be a useful quality indicator for spinal surgery. However, the rates of unplanned reoperation in patients underwent lumbar spinal surgery during the primary admission are not well established.
METHODS: This study was performed to review all the patients who underwent lumbar spinal surgery at three institutions from January 2010 to April 2015. Patients with unplanned reoperations after primary surgery during the same admission were included in this study. The demographics, diagnosis, surgical procedure, and complications of patients were reviewed and statistical analysis was performed to investigate the incidences and risk factors of unplanned revision.
RESULTS: A total of 3936 patients who underwent lumbar spinal surgery from three institutions were reviewed, and 82 (2.08%) required unplanned reoperation during the primary admission because of wound infection (0.94%), screw misplacement (0.53%), cerebrospinal fluid leakage (0.27%), wound hematoma (0.18%), and neurologic deficit (0.15%). For the diagnosis, patients with lumbar spinal spondylolisthesis had a much higher rate of reoperation (4.3%) than those of lumbar stenosis (2.3%), vertebral tumor (2.2%), vertebral fracture (1.2%), and disc herniation (1.1%) with a significant difference (P < 0.001). The revision rate was significantly higher in patients underwent posterior lumbar interbody fusion than those received transforaminal lumbar interbody fusion (P = 0.007).
CONCLUSION: Unplanned reoperation rate of lumbar spinal surgery was 2.08% and the most common reasons for it were wound infection and screw misplacement. Patients with a diagnosis of lumbar spinal spondylolisthesis or who underwent posterior lumbar interbody fusion were more likely to required unplanned reoperation during the primary admission. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2016        PMID: 26913463     DOI: 10.1097/BRS.0000000000001529

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

Review 1.  [Reasons analysis on unplanned reoperation of degenerative lumbar spine diseases].

Authors:  Ruihuan Du; Zhonghai Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-12-15

2.  Impact of Hemodialysis on Surgical Outcomes and Mortality Rate after Lumbar Spine Surgery: A Matched Cohort Study.

Authors:  Yusuke Hori; Shinji Takahashi; Hidetomi Terai; Masatoshi Hoshino; Hiromitsu Toyoda; Akinobu Suzuki; Kazunori Hayashi; Koji Tamai; Shoichiro Ohyama; Hiroaki Nakamura
Journal:  Spine Surg Relat Res       Date:  2018-08-25

3.  Repeat decompression and fusions following posterolateral fusion versus posterior/transforaminal lumbar interbody fusion for lumbar spondylosis: a national database study.

Authors:  Moon Soo Park; Young-Su Ju; Seong-Hwan Moon; Tae-Hwan Kim; Jae Keun Oh; Jin Kyu Lim; Chi Heon Kim; Chun Kee Chung; Ho Guen Chang
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

4.  Incidence and risk factors for early and late reoperation following lumbar fusion surgery.

Authors:  Shuai-Kang Wang; Peng Wang; Xiang-Yu Li; Chao Kong; Jia-Yin Niu; Shi-Bao Lu
Journal:  J Orthop Surg Res       Date:  2022-08-12       Impact factor: 2.677

5.  Complications rate of and risk factors for the unplanned reoperation of degenerative lumbar spondylolisthesis in elderly patients: a retrospective single-Centre cohort study of 33 patients.

Authors:  Weiyang Zhong; Xinjie Liang; Xiaoji Luo; Tianji Huang; Zhengxue Quan
Journal:  BMC Geriatr       Date:  2020-08-24       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.